[针对多发性骨髓瘤的新型治疗方法]
1Department of Transfusion and Cellular Therapy, Hematology, Hyogo Medical University.
概括
像CAR-T细胞疗法和针对BCMA的双特异抗体等新疗法提供了先进的多发性髓瘤治疗选择. 用传统药物对这些新型治疗方法进行测序是实现更好的患者结果的关键临床挑战.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 多发性骨髓瘤的治疗传统上依赖于免疫调节药物,蛋白酶体抑制剂和抗CD38抗体.
- 针对B细胞成熟抗原 (BCMA) 的T细胞重定向疗法的出现,包括CAR-T细胞疗法和双特异性抗体,标志着重大进展.
研究的目的:
- 审查当前多发性骨髓瘤治疗的现状,重点关注新的治疗方式.
- 讨论临床应用和测序新疗法与传统治疗的挑战.
主要方法:
- 对多发性骨髓瘤的当前临床实践和新兴治疗策略的审查.
- 在日本对CAR-T细胞治疗和双特异性抗体的治疗指示的分析.
- 对抗体-药物合物和新型标 (如GPRC5D) 的疗效评估.
主要成果:
- 在日本,CAR-T细胞疗法和针对BCMA的双特异性抗体被视为第三线治疗.
- 针对BCMA的抗体-药物合物与现有药物的组合显示出有效性.
- GPRC5D是新的双特异性抗体疗法的新兴目标.
结论:
- 针对BCMA和GPRC5D的新疗法显著扩大了多发性骨髓瘤的治疗选择.
- 尽管高效,但这些先进的治疗方法并不能治愈.
- 优化传统和新型疗法的序列是改善长期多发性骨髓瘤管理的关键挑战.
更多相关视频
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.2K
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.5K
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Tumor Immunotherapy
665
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
665
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
